ES2068742A1 - Nuevos derivados de piridinio. - Google Patents

Nuevos derivados de piridinio.

Info

Publication number
ES2068742A1
ES2068742A1 ES09300269A ES9300269A ES2068742A1 ES 2068742 A1 ES2068742 A1 ES 2068742A1 ES 09300269 A ES09300269 A ES 09300269A ES 9300269 A ES9300269 A ES 9300269A ES 2068742 A1 ES2068742 A1 ES 2068742A1
Authority
ES
Spain
Prior art keywords
alkyl
aryl
paf antagonists
pyridinium derivatives
derivatives useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09300269A
Other languages
English (en)
Other versions
ES2068742B1 (es
Inventor
Javier Bartroli
Enric Turmo
Elena Carceller
Carmen Almansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noucor Health SA
Original Assignee
J Uriach y Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by J Uriach y Cia SA filed Critical J Uriach y Cia SA
Priority to ES09300269A priority Critical patent/ES2068742B1/es
Priority to MX9400681A priority patent/MX9400681A/es
Priority to CA002114183A priority patent/CA2114183A1/en
Priority to KR1019940001742A priority patent/KR940019686A/ko
Priority to EP94102138A priority patent/EP0610943A1/en
Priority to JP6039180A priority patent/JPH06271543A/ja
Publication of ES2068742A1 publication Critical patent/ES2068742A1/es
Application granted granted Critical
Publication of ES2068742B1 publication Critical patent/ES2068742B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE PIRIDINIO DE FORMULA GENERAL I, EN DONDE RBS1 SC REPRESENTA UN GRUPO CSI1-6 SC ALQUILO O ARIL-CSI1-6 SC ALQUILO; RBS2 SC REPRESENTA UN GRUPO ARILO; R REPRESENTA UN GRUPO CSI1-18 SC ALQUILO, CSI1-18 SC HALOALQUILO, ARILO, HETEROARILO, ARIL-CSI1-6 SC ALQUILO O HETEROARIL-CSI1-6 SC ALQUILO; Z ES -O- O -NRBS3 SC-; T ES -O-, -NRBS4 SC- O BIEN REPRESENTA UN ENLACE SENCILLO; RBS3 SC Y RBS4 SC SON INDEPENDIENTEMENTE HIDROGENO CSI1-4 SC ALQUILO, ARILO, CSI1-4 SC ALQUILCARBONILO, O BIEN RBS3 SC Y RBS4 SC PUEDEN ESTAR UNIDOS FORMANDO UN CICLO, O BIEN RBS3 SC PUEDE ESTAR UNIDO A R FORMANDO UN CICLO Y W- ES UN ANION FARMACEUTICAMENTE ACEPTABLE. LA PRESENTE INVENCION DESCRIBE TAMBIEN PROCEDIMIENTOS PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN. DICHOS COMPUESTOS SON ANTAGONISTAS DEL PAF Y, POR LO TANTO, UTILES EN EL TRATAMIENTO DE LAS ENFERMEDADES EN QUE DICHA SUSTANCIA SEHALLA IMPLICADA, ESPECIALMENTE EN EL TRATAMIENTO DE LA INFLAMACION. FORMULA
ES09300269A 1993-02-11 1993-02-11 Nuevos derivados de piridinio. Expired - Fee Related ES2068742B1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES09300269A ES2068742B1 (es) 1993-02-11 1993-02-11 Nuevos derivados de piridinio.
MX9400681A MX9400681A (es) 1993-02-11 1994-01-25 Nuevos derivados de piridinio, procedimiento para su preparacion y composiciones farmaceuticas que los incluyen.
CA002114183A CA2114183A1 (en) 1993-02-11 1994-01-25 Pyridinium derivatives
KR1019940001742A KR940019686A (ko) 1993-02-11 1994-01-31 신규 피리디늄 유도체
EP94102138A EP0610943A1 (en) 1993-02-11 1994-02-11 Pyridinium derivatives useful as PAF antagonists
JP6039180A JPH06271543A (ja) 1993-02-11 1994-02-14 新規ピリジニウム誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09300269A ES2068742B1 (es) 1993-02-11 1993-02-11 Nuevos derivados de piridinio.

Publications (2)

Publication Number Publication Date
ES2068742A1 true ES2068742A1 (es) 1995-04-16
ES2068742B1 ES2068742B1 (es) 1995-11-16

Family

ID=8280764

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09300269A Expired - Fee Related ES2068742B1 (es) 1993-02-11 1993-02-11 Nuevos derivados de piridinio.

Country Status (6)

Country Link
EP (1) EP0610943A1 (es)
JP (1) JPH06271543A (es)
KR (1) KR940019686A (es)
CA (1) CA2114183A1 (es)
ES (1) ES2068742B1 (es)
MX (1) MX9400681A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2774959C (en) 2000-08-04 2016-05-31 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
WO2004030522A2 (en) 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnosis and monitoring of diseases
CA2523467C (en) * 2003-05-15 2021-10-26 Dmi Biosciences, Inc. Treatment of t-cell mediated diseases
US20070049635A1 (en) * 2003-10-31 2007-03-01 Koichi Ebihara Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
SG2014009799A (en) 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
WO2012033792A2 (en) 2010-09-07 2012-03-15 Dmi Acquisition Corp. Treatment of diseases
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
AU2012323305B2 (en) 2011-10-10 2017-07-27 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
AU2012328605B9 (en) 2011-10-28 2017-08-03 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
WO2014100352A1 (en) 2012-12-19 2014-06-26 Ampio Pharmaceuticals, Inc. Method for treatment of diseases
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
US9956217B2 (en) 2014-08-18 2018-05-01 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301751A1 (en) * 1987-07-31 1989-02-01 Takeda Chemical Industries, Ltd. Pyridinium derivatives, their production and use
EP0382380A1 (en) * 1989-01-30 1990-08-16 Takeda Chemical Industries, Ltd. Pyridinium Nitrate, its production and use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208247A (en) * 1991-08-01 1993-05-04 American Cyanamid Company Pyridinium compounds which are useful as antagonists of platelet activating factor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301751A1 (en) * 1987-07-31 1989-02-01 Takeda Chemical Industries, Ltd. Pyridinium derivatives, their production and use
EP0382380A1 (en) * 1989-01-30 1990-08-16 Takeda Chemical Industries, Ltd. Pyridinium Nitrate, its production and use

Also Published As

Publication number Publication date
CA2114183A1 (en) 1994-08-12
ES2068742B1 (es) 1995-11-16
EP0610943A1 (en) 1994-08-17
JPH06271543A (ja) 1994-09-27
MX9400681A (es) 1994-08-31
KR940019686A (ko) 1994-09-14

Similar Documents

Publication Publication Date Title
ES2068742A1 (es) Nuevos derivados de piridinio.
DK0574597T3 (da) Fremgangsmåde til fremstilling af brosluttede chirale metallocenkatalysatorer af bisindenyltypen
IL159607A0 (en) 7-amino triazolopyrimidines for controlling harmful fungi
AU1328088A (en) Herbicidal compounds
HUT74182A (en) Novel imidazole derivatives, process for producing the same and pharmaceutical compositions containing the compounds
IL98830A0 (en) Pyrimidine derivatives,process for their preparation and fungicidal compositions containing them
TW231258B (es)
ATE239708T1 (de) Huperzin-derivate, ihre herstellung und ihre verwendung
WO2003078390A8 (en) Phenolic compound and recording material containing the same
TW197421B (es)
YU28500A (sh) Postupak za dobivanje 1,4-dihidropiridina i jedinjenja koja se primenjuju u tom postupku
EP0130077A3 (en) Phenoxy derivatives, their preparation, and pharmaceutical compositions containing them
DK681487A (da) Kemisk forbindelse og anvendelse af samme som tilsaetningsmiddel til destillatbraendsel
PT79063A (en) Process for preparing herbicidal compositions and process containing 3,5-dicarboxylic acid esters of 2,6-bis-(fluoroalkyl)tetrahydropyrans and piperidines
ATE282040T1 (de) 6-phenyl-pyrazolpyrimidine
BG107358A (en) Use of phenethyl acrylamides, novel acrylamides, method for their preparation and means containing them
ATE102941T1 (de) 1-alkoxy-1-azolylmethyloxirane, verfahren zu ihrer herstellung und ihre verwendung als pflanzenschutzmittel.
WO1991006522A3 (de) Phenylcyclohexane und flüssigkristallines medium
DK0483633T3 (da) 8-Azabicyclo 3,2,1 octylalkylthiazoliddinoner, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler.
MY102290A (en) Intermediates and processes for the preparation of antihypercholesterolemic tetrazole compounds
EP0025965A3 (en) Organogermanium compounds, a method for producing them and pharmaceutical compositions comprising them
ES2024332A6 (es) Procedimiento para la obtencion de nuevas sulfonamidas.
GR3005900T3 (es)
ATE30911T1 (de) Hydrazinopyridazinverbindung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ES8802413A1 (es) Procedimiento para preparar una composicion herbicida a base de carbamoiloxi-fenilcarbamato y aceite mineral de petroleo

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000401